aminoglutethimide has been researched along with Graft vs Host Disease in 1 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vogelsang, GB | 1 |
| Hess, AD | 1 |
| Gordon, G | 1 |
| Brundrette, R | 1 |
| Santos, GW | 1 |
1 other study available for aminoglutethimide and Graft vs Host Disease
| Article | Year |
|---|---|
Thalidomide induction of bone marrow transplantation tolerance.
Topics: Aminoglutethimide; Animals; Bone Marrow Transplantation; Female; Fluorescence; Graft vs Host Disease | 1987 |